SANTA CRUZ VALLEY REGIONAL HOSPITAL
1. Target Overview & Investment Thesis
SANTA CRUZ VALLEY REGIONAL HOSPITAL is a 49-bed under-performing / distressed in PIMA, AZ with $7.6M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 46.5% Medicare, 8.2% Medicaid, and 45.3% commercial.
Thesis: Turnaround. Our ML models identify $568K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -247.7% (+748bps).
| Net Revenue HCRIS | $7.6M |
| Current EBITDA COMPUTED | $-19.4M |
| Operating Margin COMPUTED | -100.0% |
| Occupancy HCRIS | 26.7% |
| Revenue / Bed COMPUTED | $155K |
| Net-to-Gross HCRIS | 15.8% |
| Distress Probability ML | 55.1% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -100.0% places it below the state median. Among 52 size-comparable peers (24-98 beds), the median margin is 1.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (24-98), prioritizing same-state peers. 52 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SANTA CRUZ VALLEY REGIONAL HOS (Target) | AZ | 49 | $7.6M | -100.0% |
| SUMMIT HEALTHCARE | AZ | 89 | $254.1M | -2.9% |
| VERDE VALLEY MEDICAL CENTER | AZ | 87 | $172.5M | 4.3% |
| NORTHWEST MEDICAL CENTER ORO V | AZ | 96 | $145.8M | 10.6% |
| CANYON VISTA MEDICAL CENTER | AZ | 74 | $132.6M | 1.9% |
| ARIZONA GENERAL HOSPITAL | AZ | 50 | $116.2M | -6.6% |
| BANNER IRONWOOD MEDICAL CENTER | AZ | 89 | $115.5M | -1.7% |
| WESTERN ARIZONA REGIONAL MEDIC | AZ | 93 | $114.3M | 62.0% |
| HONORHEALTH SONORAN CROSSING M | AZ | 70 | $94.4M | -6.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $568K (748bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $159K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $154K | +203bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $152K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $92K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +13bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-19.4M |
| + RCM Uplift | +$568K |
| Pro Forma EBITDA | $-18.8M |
| Current Margin | -100.0% |
| Pro Forma Margin | -247.7% |
| WC Released (1x) | $291K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-29.8M | $-122.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-29.8M | $-144.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-26.8M | $-151.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-26.8M | $-173.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-32.8M | $-115.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-32.8M | $-137.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 26.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 55.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 52 hospitals with 24-98 beds
- Same-state prioritization (n=53)
- Comp margins: P25=-10.1% / P50=1.0% / P75=7.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.